Pharmabiz4h
Alnylam reports interim phase 1 data of nucresiran showing rapid knockdown of TTR that is sustained at six months following a single dose
Cambridge, Massachusetts Tuesday, November 19, 2024, 18:00 Hrs [IST] ...
Pharmabiz3h
Lupin introduces bumetanide injection, USP in United States
Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...
Pharmabiz6h
BioCryst launches Orladeyo in Ireland for routine prevention of recurrent attacks of HAE in patients 12 years and older
Research Triangle Park, North Carolina Tuesday, November 19, 2024, 16:00 Hrs [IST] ...
Pharmabiz7h
EnteroBiotix completes patient recruitment in phase 2 TrIuMPH study of EBX-102-02 in irritable bowel syndrome
Glasgow, Scotland Tuesday, November 19, 2024, 15:00 Hrs [IST] ...
Pharmabiz6h
Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records
Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records: Our Bureau, Mumbai Tuesday, November 19, 2024, 15:30 Hrs [IST] Emcure Pharmaceuticals, a l ...
Pharmabiz1h
LIfT BioSciences expands manufacturing &clinical operations with the opening of new subsidiary in Galway, Ireland
LIfT BioSciences, a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy, announces the expansion of its manufacturing and clinical ...
Pharmabiz12h
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...
Pharmabiz9h
China NMPA accepts & recommends priority review status to Ascentage Pharma’s NDA for novel Bcl-2 inhibitor, Lisaftoclax to treat r/r CLL/SLL
Rockville, Maryland Tuesday, November 19, 2024, 13:00 Hrs [IST] ...
Pharmabiz11h
Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS
Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS: Paris, France Tuesday, November 19, 2024, 11:00 H ...
Pharmabiz10h
WHO and partners rally cervical cancer elimination efforts
The Brazilian advocates behind this effort are among many around the globe joining the World Health Organization (WHO) to mobilize efforts on a worldwide “Day of Action for Cervical Cancer Elimination ...
Pharmabiz14h
DGFT overhauls export policy through harmonisation with ITC (HS) 2022 to streamline pharma export process
DGFT overhauls export policy through harmonisation with ITC (HS) 2022 to streamline pharma export process: Shardul Nautiyal, Mumbai Tuesday, November 19, 2024, 08:00 Hrs [IST] Wit ...
Pharmabiz7h
European Union recommends approval of AstraZeneca’s Tagrisso for patients with unresectable EGFR-mutated lung cancer
AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer ...